Sarepta Therapeutics
SRPT
#1513
Rank
NZ$20.09 B
Marketcap
$210.36
Share price
-0.42%
Change (1 day)
45.91%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$2.15 Billion

According to Sarepta Therapeutics 's latest financial reports the company has NZ$2.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$1.35 B124.12%
2022-12-31$NZ$0.60 B-55.37%
2021-12-31$NZ$1.35 B28.69%
2020-12-31$NZ$1.05 B-13.1%
2019-12-31$NZ$1.21 B-21.06%
2018-12-31$NZ$1.53 B38.49%
2017-12-31$NZ$1.11 B128.62%
2016-12-31$NZ$0.48 B74.77%
2015-12-31$NZ$0.27 B-12.01%
2014-12-31$NZ$0.31 B5.08%
2013-12-31$NZ$0.30 B100.08%
2012-12-31$NZ$0.15 B278.3%
2011-12-31$NZ$39.74 M-1188.41%
2010-12-31$-NZ$3.66 Million-111.22%
2009-12-31$NZ$32.53 M20.01%
2008-12-31$NZ$27.1 M-21.29%
2007-12-31$NZ$34.44 M-35.66%
2006-12-31$NZ$53.53 M-31.82%
2005-12-31$NZ$78.5 M113.25%
2004-12-31$NZ$36.81 M-44.85%
2003-12-31$NZ$66.75 M48.78%
2002-12-31$NZ$44.86 M-38.98%
2001-12-31$NZ$73.53 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$32.51 B 1,406.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.94 Billion-143.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.65 B 23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.83 Billion-138.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$57.2 M-97.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.87 Billion-186.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.85 B-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA